These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of lymphomatous diseases with triethylene melamine. MEYER LM; SCHWARTZ SO; SAWITSKY A; BEYERS MR; RITZ ND; BRAHIN C; DIEFENBACH W; KLEINSCHMIDT W; FRIEDMAN I Acta Med Scand Suppl; 1952; 272():1-36. PubMed ID: 13039963 [No Abstract] [Full Text] [Related]
3. [Treatment of hemoblastosis with triethylene melamine]. LINKE A; LASCH HG Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032 [No Abstract] [Full Text] [Related]
4. Clinical and hematologic effects of triethylene melamine. AXELROD AR; BERMAN L; MURPHY RV Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437 [No Abstract] [Full Text] [Related]
5. [Clinical trials with triethylene melamine]. FERRARI M; KASDORF H Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952 [No Abstract] [Full Text] [Related]
6. [Effect of TEM on chronic leukemia, lymphogranulomatosis and lymphosarcoma]. HAEHNER E; HEINEN W; LOOSEN H; SCHMIDT H Med Klin; 1954 May; 49(21):853-4; passim. PubMed ID: 13164965 [No Abstract] [Full Text] [Related]
7. [Immediate results of triethylene melamine therapy of neoplastic diseases]. LENTI G; GAVOSTO F Minerva Med; 1953 Jan; 44(1-2):1-19. PubMed ID: 13054386 [No Abstract] [Full Text] [Related]
9. [Our experience with the application of triethylene melamine (TEM) in patients with malignant hemopathies]. RUVIDIC R; NIKOLIC J Med Glas; 1960 Sep; 14():435-42. PubMed ID: 13744964 [No Abstract] [Full Text] [Related]
10. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias. MEZA ARRAU C; NIJAMKIN A Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308 [No Abstract] [Full Text] [Related]
11. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease. HAMBLY CK; ROBERTSON TI Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982 [No Abstract] [Full Text] [Related]
12. Triethylenemelamine and its associations in the treatment of hemolymphoblastoses and other neoplasms. MARMONT A; FUSCO F G Ital Chemioter; 1954; 1(1):193-5. PubMed ID: 13191624 [No Abstract] [Full Text] [Related]
13. [Triethylene melamine therapy of leukemia and lymphogranulomatosis]. MILIC N Lijec Vjesn; 1954; 76(1-2):40-6. PubMed ID: 13175578 [No Abstract] [Full Text] [Related]
15. [Triethylene melamine treatment of leukemia and lymphogranulomatosis]. CAKMAKCI A Turk Tip Cemiy Mecm; 1954 Jun; 20(6):290-314. PubMed ID: 13217043 [No Abstract] [Full Text] [Related]
16. [Therapy of malignant diseases with triethylene melamine]. ROMEO ORBEGOZO JM Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood]. BOCK HE; KIRBERGER E; WOELFFER U Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291 [No Abstract] [Full Text] [Related]
18. Treatment of leukemia and lymphomata with triethylene melamine. WALSH JR; PRATT PT; GRAHAM WE; ZIMMERMAN HJ Acta Haematol; 1954 Jun; 11(6):329-38. PubMed ID: 13170978 [No Abstract] [Full Text] [Related]
19. [First results of therapy with triethylene melamine]. NOWOTNA-WALCOWA R Pol Tyg Lek (Wars); 1955 Feb; 10(5):149-51. PubMed ID: 14371117 [No Abstract] [Full Text] [Related]
20. Triethylene melamine in the treatment of lymphomas and leukemias. KARNOFSKY DA Med Clin North Am; 1954 Mar; 11():541-54. PubMed ID: 13153527 [No Abstract] [Full Text] [Related] [Next] [New Search]